Clinical Trial Update: Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating sipuleucel-T, CT-011, and cyclophosphamide for advanced prostate cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatic Neoplasms

Drugs mentioned

• CT-011
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Augusta University | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2019-07-10